Showing 911-920 of 1645 results for "".
Neurotoxin Therapy: A Closer Look at the Four Options
https://practicalneurology.com/columns/practice-management/neurotoxin-therapy-a-closer-look-at-the-four-options/30818/The field of neurotoxins has grown recently, but how do the agents compare? Here's a closer look at the therapies available on the US market.Playing the Long Game: Current and Future Paths in TBI and Concussion
https://practicalneurology.com/diseases-diagnoses/tbi/playing-the-long-game-current-and-future-paths-in-tbi-and-concussion/30338/Advances in evaluation, risk stratification, and treatment of all severities of traumatic brain injury are shaping new approaches to management and prevention.Expert Opinion
https://practicalneurology.com/columns/practice-management/expert-opinion/30799/Central Diabetes Insipidus: A Case StudyCryptogenic Stroke & Atrial Fibrillation: Establishing the Link Through Team Approaches to Care
https://practicalneurology.com/diseases-diagnoses/stroke/cryptogenic-stroke--atrial-fibrillation-establishing-the-link-through-team-approaches-to-care/30393/Implementing a Cryptogenic Stroke Pathway may help reduce recurrent strokes and improve outcomes for stroke patients.Anti-Alpha-Synuclein Therapies in Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/anti-alpha-synuclein-therapies-in-parkinsons-disease/30196/Could therapies developed to stop cancers be the next breakthrough for neurodegenerative disorders?The Health Care Debate: What Will It Mean For You?
https://practicalneurology.com/columns/practice-management/PN0909_01-php/30887/The changes proposed in Congress could mean big changes to your practice. We take a look at how things could play out.Surgical Evaluation and Treatment for Genetic Epilepsies
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/surgical-evaluation-and-treatment-for-genetic-epilepsies/32053/Genetic diagnosis can be useful in guiding surgical options for genetic epilepsies.Disclosing Risk Factors to Individuals Without Cognitive Impairment
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/disclosing-risk-factors-to-individuals-withoutcognitive-impairment/31535/Negative consequences of risk factor disclosure are likely to be most severe among people who are inadequately prepared to receive the information.Beyond the Symptoms: The True Impact of gMG on Patients' Lives
https://practicalneurology.com/programs/cme/beyond-the-symptoms-the-true-impact-of-gmg-on-patients-lives/32235/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Real-World Experience Using Biomarker Testing for the Evaluation of Acute Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/real-world-experience-using-biomarker-testing-for-the-evaluation-of-acute-traumatic-brain-injury-1/32192/Integrating blood biomarker testing for traumatic brain injury into practice can help address some limitations with existing evaluative methods, leading to more timely and cost-effective diagnosis and improved health-related quality of life for affected individuals.